2026-11-08 10:13:38
Taiwan Biotech (6589) October Revenue Soars 288% Year-over-Year; EG1206A Targets 2027 Europe Launch
According to Taipei Biotech (6589), October revenue reached 270 million TWD, up 287.88% year-over-year, with cumulative revenue for the first 10 months of 2026 reaching 1.38 billion TWD, up 94.7% annually. The biotech firm attributed growth to CDMO contract manufacturing services and biosimilar drug